FDA warned Oregon's Wild Harvest after a September 2021 inspection found dietary supplement manufacturing violations: unproven identity and strength tests and foreign material in ingredients.
What happened
FDA inspected the company's Redmond, Oregon facility from September 20 to September 24, 2021. Investigators found the company had not set adequate specifications for its finished supplements and used test methods FDA considers scientifically invalid, such as treating the amount of ingredient added as proof of strength. Company records also showed quality control approved and released parts of ingredient lots that contained visible wheat, rock, tree nut shells, peanut shell, corn, rodent feces, glass, hard plastic, seed material, and an AA battery, and those materials went into products.
What FDA found
The company had no finished-product specifications for strength and composition of the ingredients in Kids Tranquil Child and Eyes Love Lutein, and the examples it later sent FDA were still inadequate.
21 CFR 111.70(e)The tests used to show identity and strength were not appropriate or scientifically valid: strength was often confirmed only by the amount of ingredient put into the batch, and the FTIR scan used could not tell similar botanicals apart.
21 CFR 111.75(h)(1)Quality control did not reject ingredient lots when allergens, filth, glass, plastic, rodent feces, or an AA battery were found; instead it approved part of the lot and the material was used in production.
21 CFR 111.113(b)(1)The company did not verify that its microbial testing methods and its in-house prepared media were suitable for their intended use, including no control showing the supplement powder itself does not stop microbial growth.
21 CFR 111.320(a)FDA also commented that the expiration dates on Stress Guard, Aller-Aid, Prostate Health, TumeriPro, and Eyes Love Lutein are not supported by data showing the product's shelf life.
72 Fed. Reg. 34752, 34856 (June 25, 2007)
What FDA wants
FDA asks the company to write within 15 working days describing the specific steps taken to correct each violation and prevent recurrence, with supporting documents; if corrections cannot be finished in that time, the company must explain the delay and say when they will be done.
Who should pay attention
- brands that buy finished dietary supplements from this manufacturer
- retailers and consumers of herbal supplement brands
- supplement makers that rely on FTIR identity scans or input-based strength checks
This is a summary. Read the original letter on fda.gov.